Back to Search
SILVA ARSLANIAN, MD
MD
Specialist
NPI: 1649242033Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
MD026458E(PA)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
PMID 21325466·J Clin Endocrinol Metab·2011
4-observational
Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth.
PMID 15616243·Diabetes Care·2005
4-observational
Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
PMID 11932281·J Clin Endocrinol Metab·2002
8-other
Hyperinsulinemia in african-american children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity.
PMID 12351441·Diabetes·2002
8-other
Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus.
PMID 12017225·J Pediatr Endocrinol Metab·2002
4-observational
Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.
PMID 11231980·J Clin Endocrinol Metab·2001
8-other
Type 2 diabetes mellitus in children: pathophysiology and risk factors.
PMID 11202214·J Pediatr Endocrinol Metab·2000
6-review
Effects of an intravenous lipid challenge and free fatty acid elevation on in vivo insulin sensitivity in African American versus Caucasian adolescents.
PMID 19017772·Diabetes Care·2009
8-other
Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients.
PMID 19073767·Diabetes·2009
8-other
Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes.
PMID 19106380·Diabetes Care·2009
2-rct
Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study.
PMID 18556675·J Pediatr Psychol·2009
8-other
In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
PMID 18835946·Diabetes Care·2009
8-other
In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children.
PMID 19675203·Diabetes Care·2009
8-other
Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon.
PMID 19466209·Arq Bras Endocrinol Metabol·2009
6-review
Menstrual health and the metabolic syndrome in adolescents.
PMID 18574212·Ann N Y Acad Sci·2008
6-review
Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus.
PMID 18589448·J Pediatr·2008
4-observational
Reproducibility of the oral glucose tolerance test in overweight children.
PMID 18713820·J Clin Endocrinol Metab·2008
8-other
Fat oxidation in black and white youth: a metabolic phenotype potentially predisposing black girls to obesity.
PMID 18782873·J Clin Endocrinol Metab·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3705 5TH AVE
PITTSBURGH, PA 15213 - Phone
- (412) 692-5170
Quick Facts
- NPI
- 1649242033
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile